Improving CRISPR-Cas technology for therapeutic applications
- Autores: Logvina N.A.1, Kopnin I.P.1, Aparin I.O.1, Zatsepin T.S.1,2
-
Afiliações:
- Center of Life Sciences, Skolkovo Institute of Science and Technology
- Chemistry Department, Lomonosov Moscow State University
- Edição: Volume 14, Nº 3 (2019): Supplement
- Páginas: 13-14
- Seção: Articles
- ##submission.dateSubmitted##: 16.01.2023
- ##submission.datePublished##: 15.12.2019
- URL: https://genescells.ru/2313-1829/article/view/122052
- DOI: https://doi.org/10.23868/gc122052
- ID: 122052
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Texto integral
Sobre autores
Nataliya Logvina
Center of Life Sciences, Skolkovo Institute of Science and Technology
Email: n.logvina@skoltech.ru
Ilya Kopnin
Center of Life Sciences, Skolkovo Institute of Science and Technology
Ilya Aparin
Center of Life Sciences, Skolkovo Institute of Science and Technology
Timofei Zatsepin
Center of Life Sciences, Skolkovo Institute of Science and Technology; Chemistry Department, Lomonosov Moscow State University
Bibliografia
Arquivos suplementares
